Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies.

Kim SY, Nair DM, Romero M, Serna VA, Koleske AJ, Woodruff TK, Kurita T.

Cell Death Differ. 2018 Jul 9. doi: 10.1038/s41418-018-0151-2. [Epub ahead of print]

PMID:
29988075
2.

Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo.

Serna VA, Wu X, Qiang W, Thomas J, Blumenfeld ML, Kurita T.

Endocr Relat Cancer. 2018 Jul;25(7):747-759. doi: 10.1530/ERC-18-0184. Epub 2018 Apr 26.

PMID:
29700012
3.

Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Wu X, Serna VA, Thomas J, Qiang W, Blumenfeld ML, Kurita T.

Cancer Res. 2017 Dec 15;77(24):6891-6901. doi: 10.1158/0008-5472.CAN-17-1744. Epub 2017 Oct 20.

PMID:
29055020
4.

Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations.

Walker CJ, O'Hern MJ, Serna VA, Kurita T, Miranda MA, Sapp CE, Mutch DG, Cohn DE, Goodfellow PJ.

Oncotarget. 2017 Aug 12;8(40):68758-68768. doi: 10.18632/oncotarget.20213. eCollection 2017 Sep 15.

5.

FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct.

Terakawa J, Rocchi A, Serna VA, Bottinger EP, Graff JM, Kurita T.

Mol Endocrinol. 2016 Jul;30(7):783-95. doi: 10.1210/me.2016-1027. Epub 2016 May 10.

6.

Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Koohestani F, Qiang W, MacNeill AL, Druschitz SA, Serna VA, Adur M, Kurita T, Nowak RA.

Hum Reprod. 2016 Jul;31(7):1540-51. doi: 10.1093/humrep/dew094. Epub 2016 Apr 29.

7.

Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.

Yin P, Ono M, Moravek MB, Coon JS 5th, Navarro A, Monsivais D, Dyson MT, Druschitz SA, Malpani SS, Serna VA, Qiang W, Chakravarti D, Kim JJ, Bulun SE.

J Clin Endocrinol Metab. 2015 Apr;100(4):E601-6. doi: 10.1210/jc.2014-2134. Epub 2015 Feb 6.

8.

Cell autonomous phosphoinositide 3-kinase activation in oocytes disrupts normal ovarian function through promoting survival and overgrowth of ovarian follicles.

Kim SY, Ebbert K, Cordeiro MH, Romero M, Zhu J, Serna VA, Whelan KA, Woodruff TK, Kurita T.

Endocrinology. 2015 Apr;156(4):1464-76. doi: 10.1210/en.2014-1926. Epub 2015 Jan 16.

9.

Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice.

Xu X, Ayub B, Liu Z, Serna VA, Qiang W, Liu Y, Hernando E, Zabludoff S, Kurita T, Kong B, Wei JJ.

Mol Cancer Ther. 2014 Jul;13(7):1729-39. doi: 10.1158/1535-7163.MCT-13-0982. Epub 2014 May 13.

10.

Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.

Qiang W, Liu Z, Serna VA, Druschitz SA, Liu Y, Espona-Fiedler M, Wei JJ, Kurita T.

Endocrinology. 2014 Mar;155(3):663-9. doi: 10.1210/en.2013-1763. Epub 2014 Jan 1.

11.

Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.

Ono M, Yin P, Navarro A, Moravek MB, Coon JS 5th, Druschitz SA, Serna VA, Qiang W, Brooks DC, Malpani SS, Ma J, Ercan CM, Mittal N, Monsivais D, Dyson MT, Yemelyanov A, Maruyama T, Chakravarti D, Kim JJ, Kurita T, Gottardi CJ, Bulun SE.

Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17053-8. doi: 10.1073/pnas.1313650110. Epub 2013 Sep 30.

12.

Diethylstilbestrol induces vaginal adenosis by disrupting SMAD/RUNX1-mediated cell fate decision in the Müllerian duct epithelium.

Laronda MM, Unno K, Ishi K, Serna VA, Butler LM, Mills AA, Orvis GD, Behringer RR, Deng C, Sinha S, Kurita T.

Dev Biol. 2013 Sep 1;381(1):5-16. doi: 10.1016/j.ydbio.2013.06.024. Epub 2013 Jul 4.

13.

Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.

Kim SY, Cordeiro MH, Serna VA, Ebbert K, Butler LM, Sinha S, Mills AA, Woodruff TK, Kurita T.

Cell Death Differ. 2013 Aug;20(8):987-97. doi: 10.1038/cdd.2013.31. Epub 2013 Apr 19.

14.

Role of stem cells in human uterine leiomyoma growth.

Ono M, Qiang W, Serna VA, Yin P, Coon JS 5th, Navarro A, Monsivais D, Kakinuma T, Dyson M, Druschitz S, Unno K, Kurita T, Bulun SE.

PLoS One. 2012;7(5):e36935. doi: 10.1371/journal.pone.0036935. Epub 2012 May 3.

15.

ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.

Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S, Sinha S.

Development. 2012 Feb;139(4):772-82. doi: 10.1242/dev.071191.

16.

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.

Melrose HL, Dächsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM, Kent CB, Korvatska E, Taylor JP, Witten L, Liang YQ, Beevers JE, Boules M, Dugger BN, Serna VA, Gaukhman A, Yu X, Castanedes-Casey M, Braithwaite AT, Ogholikhan S, Yu N, Bass D, Tyndall G, Schellenberg GD, Dickson DW, Janus C, Farrer MJ.

Neurobiol Dis. 2010 Dec;40(3):503-17. doi: 10.1016/j.nbd.2010.07.010. Epub 2010 Jul 24.

17.

Progesterone is essential for maintenance and growth of uterine leiomyoma.

Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T.

Endocrinology. 2010 Jun;151(6):2433-42. doi: 10.1210/en.2009-1225. Epub 2010 Apr 7.

Supplemental Content

Loading ...
Support Center